SEC Form 4 · accession 0001209191-16-120310
CYNOSURE INC · CYNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas J Delaney
Officer — Executive VP, Sales
Period of report
May 12, 2016
Accepted (ET)
May 16, 2016 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | May 12, 2016 | M | 2,042 | $30.51 | A | 2,042 | D | |
| Class A Common StockF2 | May 12, 2016 | S | 2,042 | $46.2364 | D | 0 | D | |
| Class A Common StockF2 | May 12, 2016 | S | 4,424 | $46.2364 | D | 0 | D | |
| Class A Common Stock | May 13, 2016 | M | 5,833 | $29.40 | A | 5,833 | D | |
| Class A Common StockF3 | May 13, 2016 | S | 5,833 | $47.0007 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F4 | $30.51 | May 12, 2016 | M | 2,042 | D | — | Feb 11, 2025 | Class A Common Stock | 2,042 | 14,292 | D |
| Employee Stock Option (right to buy)F5 | $29.40 | May 13, 2016 | M | 5,833 | D | — | Feb 13, 2024 | Class A Common Stock | 5,833 | 17,501 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The sales price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $45.27 to $47.61 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F3The sales price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $46.29 to $47.49 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F4The option became exercisable as to approximately 8.33% of the shares on each three-month anniversary of the 2/11/2015 grant date.
- F5The option became exercisable as to approximately 8.33% of the shares on each three-month anniversary of the 2/13/2014 grant date.